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Background. Common mental disorders (CMD) are among the most signiﬁcant contributors to disability worldwide.
Patient-reported disability outcomes should be included as a key metric in the comparative assessment of value across
global mental health interventions. This study aims to evaluate the validity of a widely used, cross-cultural tool – the 12-
item World Health Organization Disability Assessment Schedule II (WHODAS) – as a functional outcome measure for
CMD treatment.
Methods. The study population includes 1024 participants with CMD enrolled in the MANAS trial in India. CMD was
assessed using the Revised Clinical Interview Schedule (CIS-R). Disability was assessed using the 12-item WHODAS II
plus a measure of disability days. This analysis presents the correlations between these disability items and CMD symp-
tom severity at 2 months after enrollment (convergent validity) and the items’ associations with CMD recovery 4 months
later (external responsiveness).
Results. All items showed a positive correlation of disability with CMD symptom severity (p < 0.001). The WHODAS
items of ‘standing,’ ‘household responsibilities,’ and ‘emotional disturbance’ explained the most variance in CMD symp-
tom severity. Improvements in ‘disability days,’ ‘emotional disturbance,’ ‘standing,’ ‘household responsibilities,’ ‘day-to-
day work,’ and ‘concentrating’ were signiﬁcantly associated with CMD recovery over follow-up.
Conclusions. Further research is recommended on a CMD-speciﬁc WHODAS subscale comprised of the six WHODAS
items found to be most strongly associated with CMD severity and recovery. This shorter, CMD-speciﬁc disability sub-
scale would critically serve as a common metric to compare intervention impact on patient-centered outcomes and, in
turn, to allocate global mental health resources eﬃciently.
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Background
Common mental disorders (CMD), comprising de-
pressive and anxiety disorders, cause signiﬁcant dis-
ability worldwide, with depressive disorders alone
estimated to be the second leading global contributor
(Ferrari et al. 2013). CMD are associated with such
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disabling consequences as diminished economic pro-
ductivity, loss of employment, and impaired social
functioning and, overall, contribute substantial socioe-
conomic burdens on patients and communities (Ormel
et al. 1994; Judd et al. 2000; Patel et al. 2010; Silva et al.
2013). In part due to the large burden of CMD globally,
particularly in low- and middle-income countries with
wide treatment gaps, the regular assessment of dis-
ability outcomes of mental health interventions has
been selected as one of the top 25 research priorities
for the ﬁeld of global mental health through a Delphi
panel of hundreds of international stakeholders
(Collins et al. 2011).
Disability isdeﬁnedby theWorldHealthOrganization
(WHO) as the disruption of an individual’s interaction
with his or her environment (WHO, 2010). A common
metric of self-reported disability is a necessary tool for
the evaluation and comparison of intervention impact
on outcomes that matter to patients. While the diversity
and reach of psychosocial treatments for commonmental
disorders have been rapidly growing over the past sev-
eral decades, a recent systematic search found that
fewer than 5% of clinical trials for the treatment of de-
pression reported a measure of functional outcomes
(McKnight & Kashdan, 2009). In the burgeoning move-
ment that extends and tailors mental health treatments
to new cultures and contexts, there is a need for a com-
mon metric for mental health program evaluation that
includes patient-centered outcomes.
Due to itswidespread internationaluse, soundpsycho-
metric properties, and ease of administration, the WHO
Disability Assessment Schedule II (WHODAS) is a
prime candidate for the routine evaluation of inter-
vention impact on patient-reported disability outcomes
(WHO, 2010). Developed in 1998, the WHODAS is a
cross-cultural tool that captures social, occupational,
physical, and role impairments associated with a health
condition (WHO, 2010). As a component in disease bur-
den calculations (i.e. through Disability-Adjusted Life
Years), the WHODAS enables the comparison of cost-
eﬀectiveness across diverse health interventions,
which in turn guides planning of health policies and
programs. While the WHODAS has heretofore been
used primarily to assess disability associated with
physical illnesses, the WHODAS is being increasingly
applied to study disability among psychiatric popula-
tions in low- and middle-income countries. For
example, it has been applied to assess functional impair-
ments associated with mental disorders, understand
relationships between mental illness and physical
comorbidities, and measure mental health treatment
outcomes (Akinsulore et al. 2015, De Silva et al. 2015,
Faye et al. 2015).
This study aims to take the ﬁrst step in evaluating
the WHODAS as an outcome measure for CMD
treatment by assessing the convergent validity of
WHODAS disability items with CMD severity and the
external responsiveness of items to recovery from
CMD. The individual WHODAS items found to be
more correlated to CMD severity and responsive to
CMD recovery are furthermore recommended as candi-
dates for future development of a CMD-speciﬁc
WHODAS subscale. This subscale would strengthen as-
sessment of functional outcomes in studies of CMD
recovery.
Methods
Study sample
The study sample for this secondary analysis includes
patients enrolled in a cluster randomized controlled
trial of CMD treatments in Goa, India (the MANAS
trial) (Chatterjee et al., 2008; Patel et al. 2010, 2011).
This sample includes patients diagnosed with CMD,
according to the International Statistical Classiﬁcation
of Diseases and Related Health Problems – 10th re-
vision (ICD-10), being treated in the collaborative
stepped-care (n = 423) and enhanced usual care (n =
601) arms. Conducted between 2007 and 2009, the
MANAS trial included 2796 adult primary care atten-
ders who screened positive for CMD according to the
12-item General Health Questionnaire (GHQ) in 12
public health centers and 12 private general prac-
titioner clinics. Details of the study design, the baseline
characteristics of participants, and the treatments ef-
fects on CMD and disability outcomes have been pub-
lished elsewhere (Chatterjee et al. 2008; Patel et al. 2008,
2010, 2011). The MANAS trial is registered with
ClinicalTrials.gov with identiﬁer NCT00445407.
Study design
Disability measurements were taken at the 2-, 6-, and
12-month time points after enrollment in the MANAS
trial. Of the 2491 participants attending the 2-month
follow-up, 1024 (41.1%) maintained a diagnosis of
CMD. This subsample of 1024 participants was in-
cluded in the current analysis as a cohort followed
from 2 to 6 months after enrollment.
Instruments
Clinical outcomes were measured with the Revised
Clinical Interview Schedule (CIS-R), a standardized,
structured CMD diagnostic tool that has been ﬁeld-
tested for use in Goa (Lewis et al. 1992; Patel et al.
1998, 2011). Lay health workers used the CIS-R to gen-
erate an ICD-10 diagnosis and a symptom severity
score (0–57) at each follow-up point (Patel et al. 2010).
Recovery from CMD at the 6-month follow-up visit
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was determined with the CIS-R according to ICD-10
criteria (Patel et al. 2010).
Disability outcomes were assessed using the 12-item
WHODAS II, and two items from the 36-item
WHODAS II. The WHODAS II measures items in six
domains of functioning as experienced over the past
30 days: mobility, self-care, life activities, understand-
ing and communicating (U&C), interpersonal interac-
tions, and participation in society (WHO, 2010). The
12-item tool assesses each domain with two items
that are measured on a 3-point scale in which 1 indi-
cates no disability, 2 indicates mild to moderate dis-
ability, and 3 indicates severe to extreme disability.
These items were summed to generate a total score be-
tween 12 (no disability) and 36 (maximum disability).
A total number of disability days were computed
from two items of the 36-item WHODAS assessing
days of no work or of reduced work due to illness in
the past 30 days and was assessed by lay health work-
ers if patients reported at least mild disability on any of
the 12 WHODAS items (Patel et al. 2008).
Statistical analyses
The convergent validity of each WHODAS item with
the CIS-R symptom severity score was evaluated
using a non-parametric equivalent of the Pearson’s cor-
relation coeﬃcient, Spearman’s rank-order correlation
coeﬃcient rs, which indicates the extent of correlation
between the disability item score and the CIS-R score.
Similar to squaring Pearson’s correlation coeﬃcient,
Spearman’s rank-order correlation coeﬃcient may be
squared (r2s ) to estimate the variance in CIS-R scores
explainedby thedisability itemscore as an eﬀect size stat-
istic (Rosenthal, 1994; Pett, 1997). Qualitative evaluations
were used to assess the degree of correlation, with
Pearson’s correlationvaluesof approximately 0 (no corre-
lation to weak correlation), ±0.50 (moderate correlation),
±0.71 (high correlation), and±1 (perfect correlation) corre-
sponding to Spearman’s rank correlations of 0, ±0.48,
±0.69 and ±1 (Kirkwood & Sterne, 2003).
To identify which speciﬁc aspects of disability were
most responsive to recovery, we used logistic re-
gression to estimate magnitude of the relationship be-
tween change in individual WHODAS items and the
CMD recovery outcome (i.e. external responsiveness).
Recovery from CMD between the 2- and 6-month
follow-up points was analyzed as the dependent vari-
able. The change scores for each of the 12 WHODAS
items, the global WHODAS score, and the total num-
ber of disability days were coded into binary measures
of 0 = ‘not improved’ and 1 = ‘improved’. Each
WHODAS measure was analyzed as an independent
variable in separate logistic regression models, con-
trolled for baseline CIS-R score, sex, age, clinic type,
and intervention arm as potential confounders.
Cluster robust standard errors (S.E.) were applied to ad-
just the 95% conﬁdence intervals (CI) for clinic-level
clustering.
Results
Sample characteristics
The sociodemographic and clinical characteristics of
the sample at the 2-month follow-up are presented in
Table 1. They had a mean age of 48.0 years (S.D. =
13.6) and were predominantly female (85.8%), married
(61.7%), and Hindu (70.2%). Half had no formal
Table 1. Distribution of study sample characteristics at 2 months
after recruitment into the MANAS trial, India, 2007–2009
Sociodemographic
characteristics
Mean (S.D.)/
number (%)
Age (n = 1024) 48.0 (13.6)
Sex (n = 1024) Female 878 (85.8)
Male 146 (14.2)
Education level
(n = 1024)
<1 year 512 (50.0)
1–5 years 230 (22.5)
≥6 years 282 (27.5)
Employment (n = 1023) Unemployed 731 (71.5)
Full-time 126 (12.3)
Part-time/seasonal 150 (14.7)
Other 16 (1.6)
Marital status
(n = 1024)
Married 632 (61.7)
Widowed or
separated/
divorced
339 (33.1)
Never married 53 (5.2)
Ethnicity (n = 1024) Goan 974 (95.1)
Other 50 (4.9)
Religion (n = 1024) Hindu 719 (70.2)
Christian 288 (28.1)
Muslim 16 (1.6)
Financial status
(n = 1024)
Living
comfortably
64 (6.3)
Just getting by 361 (35.3)
Difﬁcult to make
ends meet
599 (58.5)
Clinical characteristics Median (IQR; range)
CIS-R score (n = 1024) 18 (14–24; 0–57)
Twelve-item WHODAS II
global score (n = 1024)
19 (16–22; 12–36)
Disability days score (n = 965) 15 (0–30; 0–30)
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education (50.0%), and a majority was unemployed
(71.5%). The median CIS-R score was 18 out of 57
(IQR: 14–24), the median WHODAS score 19 out of
36 (IQR: 16–22), and the median disability days score
15 out of 30 (IQR: 0–30). Of the initial 1024 partici-
pants, 943 (92.1%) were seen at 6 months, and of
these, 368 participants (39.0%) had recovered from
CMD. At both 2 and 6 months, respectively, only
four patients (0.4%) had missing values for the dis-
ability days score.
Convergent Validity
Convergent validity statistics are presented in Fig. 1.
All of the disability items had weak but signiﬁcant cor-
relations with CIS-R scores, with rs values between
0.14 and 0.39. ‘Household responsibilities,’ ‘emotional
disturbance,’ and ‘standing’ explained the most vari-
ance in CIS-R scores (r2s values of 0.15, 0.10, and 0.09,
respectively). The WHODAS global score showed the
greatest extent of correlation with the CIS-R scores
(rs = 0.42), yet remained only moderate, explaining
18% of the variance in CIS-R scores (r2s = 0.18).
External Responsiveness
As presented in Table 2, improvement in the WHODAS
global score, disability days score, and ﬁve of the 12
WHODAS item scores were associated with CMD
recovery. Participants whose global WHODAS scores
improved between 2 and 6 months follow-up had on av-
erage 2.40 times higher odds of having recovered from
CMD [adjusted Odds Ratio (aOR) 95% CI: 1.62–3.56].
Those who reported fewer disability days at 6 months
had 2.37 higher odds of recovery (aOR 95% CI: 1.66–
3.37). Of the 12 individual WHODAS items, ﬁve dis-
played evidence of signiﬁcant responsiveness to CMD
recovery: ‘emotional disturbance,’ ‘standing,’ ‘household
responsibilities,’ ‘day-to-day work,’ and ‘concentrating.’
Conclusions
This study constitutes, to our knowledge, the ﬁrst as-
sessment of the validity of the 12-item WHODAS II
among middle-aged patients with CMD in a low- or
middle-income country. Previous studies have ana-
lyzed associations between measures of disability
and CMD at a single time point or changes in disability
over time as estimates of internal responsiveness with-
out reference to CMD caseness (Judd et al. 2000; Garin
et al. 2010). As a longitudinal treatment study, this
study importantly adds quantiﬁcations of the associa-
tions between concurrent changes in disability and
CMD caseness to the evidence base.
The present study found that ﬁve items in the
domains of participation (‘emotional disturbance’),
physical mobility (‘standing’), life activities
Fig. 1. Convergent validity of CMD symptom severity scores with WHODAS disability measures at 2 months among
participants of the MANAS trial, India, 2007–2009.
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(‘household responsibilities’ and ‘day-to-day work’),
and understanding and communicating (‘concentrat-
ing’) most strongly correlated with symptom severity
in the cross-section and responded to CMD recovery.
In contrast, items in the interpersonal and self-care
domains showed little to no relationship with severity
or recovery. Despite weak convergent validity, the dis-
ability days score showed strong responsiveness to re-
covery. Although correlation coeﬃcients for all
WHODAS items with CIS-R scores were weak, ﬁve
WHODAS items and the disability days item showed
the greatest extent of correlation with CMD severity
and signiﬁcant associations with CMD recovery;
thus, these six WHODAS items are recommended for
further research in the development of a
CMD-speciﬁc subscale.
This pattern of results largely aligns with studies of
patients with depression in Europe and the USA in
which the WHODAS domains of participation and
life activities have been found to be the most internally
responsive (i.e. change over time) (Chwastiak & Von
Korﬀ, 2003; Garin et al. 2010). In contrast to
Chwastiak & Von Korﬀ (2003), this study found the
self-care domain to be responsive and the interpersonal
domain to be largely unresponsive. However, in this
study few patients with CMD experienced disability
in this domain at 2 months, and it is possible that
gains in interpersonal functioning occurred largely
within the ﬁrst 2 months of the trial.
Unlike much of the research on patients with de-
pression in high-income countries, physical mobility
items showed strong responsiveness. A qualitative
study of the MANAS trial found weakness/tiredness
to be one of the two most commonly reported reasons
for seeking care, suggesting a somatic manifestation of
CMD in this context (Andrew et al. 2012). Thus, the
physical mobility domain may be heterogeneously
associated with CMD cross-culturally, and the relation-
ship may diﬀer for those with anxiety versus those
with depressive disorders.
The observed external responsiveness of the dis-
ability days measure to CMD recovery is consistent
with ﬁndings from a review of depression treatment
studies in high-income settings. Notably, Mintz et al.
(1992) found that work role impairments, including
disability days, were more consistently alleviated
when patients’ symptoms were also alleviated and,
moreover, that most of the variance in work outcomes
over the course of treatment was attributable to symp-
tom remission.
This study has several limitations. First, sample
selection limits the generalizability. As disability was
not measured at trial baseline, this study includes
patients who presented with CMD at 2 months and
thus were experiencing more chronic episodes of
CMD. Moreover, at this follow-up point, 305 patients
(10.9%) enrolled in the trial at baseline were missing
at 2 months and these missing patients were more
likely to be male, younger, and have less severe
CMD. The WHODAS assessment did not take place
during trial enrollment, during patient primary care
visits, in order to minimize the burden on participants.
The WHODAS assessments took place at 2 and 6
months, with all other follow-up assessments, during
Table 2. External responsiveness of improvements in disability items with CMD recovery at 6 months among participants of the MANAS
trial, India, 2007–2009
Domain Item Adjusted OR (95% CI)
12-item WHODAS II (n = 943) Mobility Standing 1.67 (1.19–2.34)***
Walking a kilometer 1.23 (0.87–1.72)
Self-care Washing whole body 1.10 (0.69–1.75)
Getting dressed 0.83 (0.51–1.34)
Understanding and
communicating
Concentrating 1.30 (1.01–1.67)**
Learning a new task 0.99 (0.70–1.40)
Inter-personal Maintaining a friendship 0.76 (0.36–1.58)
Dealing with strangers 0.94 (0.52–1.69)
Life activities Household responsibilities 1.67 (1.19–2.34)***
Day-to-day work 1.40 (1.01–1.94)**
Participation Community participation 1.03 (0.70–1.50)
Emotional disturbance 1.81 (1.27–2.58)***
Global score 2.40 (1.62–3.56)***
Disability days in past month (n = 836) 2.37 (1.66–3.37)***
Odds ratios adjusted for baseline CIS-R score, sex, age, clinic type, and intervention arm, with cluster robust standard errors
(S.E.).
* p < 0.1, ** p < 0.05, *** p < 0.01, p value from Wald test in fully adjusted model.
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planned visits to participants’ homes. Second, the
‘U-shaped’ distribution of the disability days scores,
being clustered largely around 0 and 30 days with a
small peak at 15 days, suggests recall bias. Because
this bias has unpredictable implications for the results,
the disability days statistics should be interpreted with
caution. Lastly, during piloting the research team
observed that participants found the ﬁne judgments
required of the 5-point WHODAS scale diﬃcult and
thus collapsed the WHODAS scale to three points in
the trial. This 3-point response scale did not allow for
a ﬁne-grained assessment of responsiveness. In ad-
dition, an implication of this collapse of the scale for in-
dividual WHODAS items is non-diﬀerential
misclassiﬁcation of the WHODAS scores, and thus
bias toward the null when assessing correlation and re-
gression coeﬃcients for WHODAS items.
This study provides a foundational step in the devel-
opment of a common disability metric for evaluating
mental health treatment outcomes. The ﬁndings sug-
gest that a WHODAS subscale of the six items found
to be most strongly associated with CMD severity
and recovery could provide a more valid and meaning-
ful measure of CMD recovery in evaluations of CMD
interventions. Future research is recommended to con-
ﬁrm the scale reduction of the WHODAS, as evaluated
here, by measuring the WHODAS items on a 5-point
response scale and using item-response theory meth-
ods, such as those used in Bokken (1971). Prior to its
use across mental health evaluation studies, the result-
ing subscale would need to be validated among pri-
mary care-seeking populations with CMD in several
low- and middle-income countries. The routine use of
this CMD-speciﬁc subscale of the WHODAS would
serve as a critical component of an evidence-based,
cost-eﬃcient, and patient-centered response to the
challenge of global mental health.
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